Keyphrases
Medicaid Expansion
63%
Medicaid Patients
59%
Thyroid Cancer
58%
COVID-19
58%
Endocrine Surgery
57%
Surgeons
55%
Metastatic Disease
54%
Adrenalectomy
51%
High-volume Center
50%
Affordable Care Act
50%
Positive Predictive Value
46%
COVID-19 Pandemic
46%
Thyroidectomy
44%
Thyroid Surgery
41%
Primary Aldosteronism
40%
Surgical Resection
40%
Advanced Disease
33%
Systemic Therapy
33%
Ultrasound
33%
Nodule
31%
Surgical Pathology
31%
Sensitivity Specificity
30%
Negative Predictive Value
30%
Endocrine Surgeons
30%
Surgical Conditions
30%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
30%
Medical Management
28%
Surgical Management
28%
Overall Survival
28%
Improved Outcomes
28%
Tumor Grade
28%
Gastric Neuroendocrine Tumors
28%
Pancreatic Neuroendocrine Tumors (pNETs)
28%
Oncological Outcomes
28%
Advanced or Metastatic
27%
Clinical Data
25%
Operative Time
25%
Operating Room
25%
Hispanic Population
25%
IoPTH
25%
Intact Parathyroid Hormone (iPTH)
25%
Operative Costs
25%
Duodenal Neuroendocrine Tumor
25%
Nonfunctional Pancreatic Neuroendocrine Tumor
25%
Black Population
25%
Adrenal Incidentaloma
25%
Adrenal Vein Sampling
25%
Adrenocortical Carcinoma
25%
MicroRNA Classifier
25%
Inappropriate Use
25%
Malpractice Claims
25%
Cytologically Indeterminate Thyroid Nodules
25%
Early Diagnosis
25%
Tumor Genotyping
25%
Clinical Phenotype
25%
Worse Prognosis
25%
Differentiated Thyroid Carcinoma
25%
Lymph Node Dissection
25%
Papillary Thyroid Cancer
25%
COVID-19 Pandemic Impact
25%
Thyroid Malignancy
25%
Insurance Type
25%
Ultrasound Features
25%
Genotype
25%
Hereditary Conditions
25%
Lymph Node
25%
Surgical Removal
25%
Tyrosine Kinase Inhibitor
25%
Hereditary Disease
25%
Medullary Thyroid Cancer
25%
Sonographic
25%
Total Thyroidectomy
25%
Prophylactic Surgery
25%
Calcitonin
25%
All Diseases
25%
High Specificity
25%
Radical Antegrade Modular Pancreatosplenectomy (RAMPS)
25%
Timing of Surgery
25%
Surgery Alone
25%
Lymphatic Spread
25%
Confidence Interval
25%
Northeastern United States
25%
Surgical Oncology
25%
KRAS mutation
25%
Comprehensive Cancer Center
25%
Surgery Patients
25%
Treatment Delay
25%
Practice Experience
25%
United States
25%
Oncology Practice
25%
Pheochromocytoma
25%
Coronavirus Impact
25%
Radiology Reports
25%
Immediate Effect
25%
Limited Disease
25%
Guideline Adherence
25%
Clinical Utility
25%
Odds Ratio
25%
Bethesda
25%
Insurance Coverage
25%
Carcinoid
25%
Benign Disease
25%
Disease Progression
25%
Paraganglioma
25%
Reoperative
25%
Racial-ethnic Groups
25%
Multi-institutional Study
25%
Primary Hyperparathyroidism (pHPT)
25%
Cytopathology
25%
Operative Volume
22%
Thyroid Patients
21%
Difference Analysis
21%
Endocrine Disorders
21%
Vizient
20%
Uninsured Patients
19%
Clinical Efficacy
18%
ThyraMIR
18%
Probabilistic Sensitivity Analysis
18%
Four-dimensional Computed Tomography
18%
Insurance Status
18%
National Cancer Database
16%
Fatty
16%
Office-based Procedures
16%
Architectural Distortion
16%
Hilum
16%
Virtual Platform
16%
Lymph Node Mapping
16%
Private Health Insurance
16%
Adrenal Disease
16%
Parathyroid Disease
16%
Tumor Characteristics
16%
Hispanic
15%
Distal Pancreatectomy
15%
Medicaid Coverage
15%
Turnaround Time
15%
Affordable Care Act Medicaid Expansion
14%
Tort Reform
14%
Hazard Ratio
14%
Neuroendocrine Tumor
13%
Postoperative Outcomes
12%
Liver
12%
Stage at Presentation
12%
Therapeutic Intervention
12%
Therapeutic Potential
12%
Treatment Options
12%
Genetic Syndromes
12%
Black Men
12%
Tumor Stage
12%
Primary Tumor
12%
Bethesda System
12%
African American
12%
Coronavirus Disease (COVID)
12%
Subspecialty
12%
White People
12%
Difference-in-differences
12%
American Thyroid Association Guidelines
11%
Benign Thyroid Disease
11%
Malignancy
11%
Medical Therapy
11%
Parathyroidectomy
11%
Retrospective Chart Review
11%
Differentiated Thyroid Cancer
10%
Litigation
10%
Multivariable
10%
Retrospective Review
10%
Cost Reduction
10%
Computed Tomography
10%
Outpatient Referral
10%
Referral Rate
10%
Delayed Care
10%
Operative Plan
10%
November 7
10%
High-volume Surgeon
9%
Adjusted Odds Ratio
9%
Hispanic Patients
9%
Risk of Malignancy
9%
Patient Demographics
8%
Paired T-test
8%
Ultrasound Findings
8%
Fine-needle Aspiration
8%
High Sensitivity
8%
Sonographic Features
8%
Chi-square
8%
Adrenal Malignancy
8%
Backlog
8%
Risk Stratification System
8%
Clinical Impact
8%
Nodal Metastasis
8%
Any Dimension
8%
Microcalcification
8%
Educational Needs
8%
Professional Impact
8%
Node Features
8%
Clinical Volume
8%
Malignant Lymph Node
8%
Elective Surgery
8%
Educational Impact
8%
Hormone Production
8%
Logistic Regression
8%
ICD-10
8%
High-grade Tumor
8%
Endocrine Cancer
8%
Etiology
8%
Gynecologic Oncology
8%
Negative Binomial Regression
8%
Pre-pandemic
8%
Endoscopic Resection
8%
United States Healthcare System
8%
CPT Codes
8%
Tumor Subtype
8%
State Medicaid Expansion
8%
Control Chart
8%
Clinical Setting
8%
Demographic Trends
8%
Tumor-specific
8%
Specific Factors
8%
Chart Analysis
8%
New Patients
8%
Access to Care
8%
Reduced Survival
8%
Metastatic Papillary Thyroid Cancer
8%
Patient Visits
8%
Antihypertensive Medication
8%
Radionuclides
7%
Resection
7%
Age-grading
7%
Lymphovascular Invasion
7%
Surgery Fellowship
7%
Radioactive Iodine Therapy
7%
Lobectomy
7%
Undertreatment
7%
Radioactive Iodine
7%
Medicaid
7%
Systolic Blood Pressure
6%
Adrenal Nodule
6%
Univariate Analysis
6%
Thyroid Cytopathology
6%
Ultrasound-guided Fine-needle Aspiration
6%
Ultrasonic Localization
6%
Ultrasound-guided FNA
6%
Area under the Curve
6%
Medicaid Access
6%
Thyroid Cancer Surgery
6%
Biologic Activity
6%
Pancreatic Ductal Adenocarcinoma
6%
Thyroid Fine-needle Aspiration
6%
Bethesda II
6%
Localization Technique
6%
Carcinoma
6%
Surgery Department
6%
Tumor
6%
Preoperative Localization
6%
Decision-analytic Model
6%
PTH Assay
6%
Base-case Model
6%
Recurrent Disease
6%
Health Systems
6%
Cost-effectiveness
6%
Molecular Diagnostics
6%
Predictive Value
6%
Payer Mix
6%
Confirmatory Test
6%
Pancreas
6%
Clinical Decisions
6%
Comorbidity
5%
Aldosterone
5%
Cost Model
5%
Health Care Costs
5%
In(III)
5%
Immunoassay
5%
Biochemical Cure
5%
Demographic Data
5%
Total Parathyroidectomy
5%
Nodule Type
5%
Machine Time
5%
COVID-19 Delays
5%
Course of Action
5%
Disease-related
5%
Abdomen
5%
Laboratory Turnaround Time
5%
Primary Tumor Site
5%
Medical Outpatients
5%
Treatment Plan
5%
Adrenal Mass
5%
Non-associated
5%
Clinical Presentation
5%
Elective Surgical Procedures
5%
With Woman
5%
COVID-19 Related
5%
Care Delivery
5%
Demographic Information
5%
Primary Diagnosis
5%
Nodule Size
5%
Clinical Outcomes
5%
Inclusion Criteria
5%
Medical History
5%
Outpatient Assessment
5%
COVID-19 Impact
5%
Pelvis
5%
Radiological Findings
5%
Medicine and Dentistry
COVID-19
100%
Surgery
89%
Surgeon
76%
Diseases
70%
Neoplasm
67%
Thyroid Gland
63%
Thyroidectomy
60%
Adrenalectomy
60%
Endocrine Surgery
57%
Thyroid Surgery
55%
Thyroid Cancer
54%
Health Care Cost
50%
Malignant Neoplasm
46%
Cancer
44%
Parathyroid
42%
Primary Hyperaldosteronism
40%
Neuroendocrine Tumor
37%
Parathyroid Hormone
32%
Overall Survival
31%
Odds Ratio
31%
Base
30%
Endocrine Disease
30%
Metastatic Carcinoma
29%
Pancreas Islet Cell Tumor
27%
Operation Duration
25%
Carcinoid
25%
Cytopathology
25%
Gastroenteropancreatic Neuroendocrine Tumor
25%
Paraganglioma
25%
Pheochromocytoma
25%
Operating Room
25%
Ethnic Group
25%
Adrenal Incidentaloma
25%
Adrenal Cortex Carcinoma
25%
Primary Hyperparathyroidism
25%
Distal Pancreatectomy
25%
Papillary Thyroid Cancer
25%
Disease Exacerbation
25%
microRNA
25%
Lymph Flow
25%
Adrenal Disease
25%
Differentiated Thyroid Cancer
25%
Therapy Delay
25%
Parathyroid Disease
25%
Benign Tumor
25%
Lymph Node
25%
Radioactive Iodine
25%
Thyroid Nodule
25%
Hazard Ratio
25%
Surgical Oncology
25%
Outpatient
25%
Patient Referral
25%
Radiology
25%
Protocol Compliance
25%
Lobectomy
20%
Thyroid Disease
18%
Systemic Therapy
17%
Fine-Needle Aspiration
13%
Systolic Blood Pressure
13%
Bethesda System
12%
Endocrine Cancer
12%
Logistic Regression Analysis
12%
Central Lymph Nodes
12%
Early Diagnosis
12%
Retroperitoneal Lymph Node Dissection
12%
Calcitonin
12%
Tyrosine-Kinase Inhibitor
12%
Antihypertensive Agent
11%
Surgical Margin
10%
Four Dimensional Computed Tomography
10%
Parathyroidectomy
10%
Secretion (Process)
10%
Pancreas Adenocarcinoma
10%
Adrenal Gland
10%
Computer Assisted Tomography
10%
Elective Surgery
9%
Radioisotope
9%
Comorbidity
8%
Sensitivity and Specificity
8%
Genetic Disorder
8%
Clinical Stage
8%
Primary Tumor
8%
Carcinoma
8%
Diagnosis
8%
Subgroup Analysis
8%
Cancer Diagnosis
8%
Tertiary Care
8%
Telehealth
8%
Gynecological Oncology
8%
Aldosterone
8%
Combination Therapy
7%
Lymphovascular Invasion
7%
Univariate Analysis
6%
Recurrent Disease
6%
Health Care
6%
Medicare
6%
Decision Making
5%
Resistant Hypertension
5%
Awareness
5%
Body Mass Index
5%
Blood Pressure
5%
Renin
5%
Endoscopic Surgery
5%
Specific Tumor
5%
Hormone Synthesis
5%
Quality Improvement
5%
Thyroid Cancer Surgery
5%
Pancreatectomy
5%
Pancreatic Surgery
5%
Current Procedural Terminology
5%
Primary Health Care
5%
Pelvis
5%
Population Dynamics
5%
Medical History
5%